Oncology Lung cancer vaccine renews synthetic DNA discussions pharmaphorum spoke with Dr Amy Walker, CEO of 4basebio, about personalised cancer vaccines and synthetic DNA.
Oncology How precision medicine treats an overlooked clinical variabl... In oncology, time is not simply a measure of care; it is a clinical variable – and increasingly a therapeutic challenge.
Oncology On the benefits of earlier oncological intervention, with Jo... As ESMO 2026 came to a close, pharmaphorum web editor Nicole Raleigh spoke with Johnson & Johnson Innovative Medicine’s Carolyn Sousa and Henar Hevia
Oncology Sponsored Global oncology innovation from Hengrui Pharma Hengrui Pharma's strategic ambition in oncology has focused on translating scientific innovation into meaningful treatment options for patients.
Oncology How AI is advancing patient subgroup identification in oncol... With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.
Oncology Personal reflections on World ADC, San Diego At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.
News Lilly partners with Hims & Hers on obesity drug sales Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the telehealth company's platform.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
